Protagenic Therapeutics, Inc.
PTIX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001022899
In the last 90 days, Protagenic Therapeutics, Inc. insiders filed 7 open-market purchases and 0 sales; 2 institutions reported holding it in 13F filings for Q2 2026, worth $25.4K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Protagenic Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 9 | 11 | +2 |
| Shares | 337.8K | 70.6K | −267.1K (−79.1%) |
| Value | $65.9K | $258.1K | +$192.2K (+291.8%) |
New holders (7)
Institutions that held Protagenic Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alpine Global Management, LLC | 16,351 | $59.7K | 0.01% |
| Morgan Stanley | 15,002 | $54.8K | 0.00% |
| Susquehanna International Group, LLP | 10,156 | $37.1K | 0.00% |
| UBS Group AG | 9,020 | $32.9K | 0.00% |
| Citigroup Inc | 390 | $1.42K | 0.00% |
| Raymond James Financial Inc | 1 | $4 | 0.00% |
| Harbor Investment Advisory, LLC | 1 | $4 | 0.00% |
Sold out (5)
Institutions that held Protagenic Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| HRT Financial LP | 124,015 | $24.0K |
| Geode Capital Management, LLC | 77,296 | $15.1K |
| Vanguard Group Inc | 33,166 | $6.47K |
| Two Sigma Securities, LLC | 27,968 | $5.46K |
| State Street Corp | 13,812 | $2.69K |